MediKarma has proven that autonomous AI agents can deliver measurable clinical outcomes in real-world deployment, not just talk to patients but actually improve their health metrics. The 50% A1C reduction in a controlled study validates that AI can move beyond administrative tasks into therapeutic intervention, especially crucial given the 20,000-unit deployment with Family Health Choice proves this scales beyond pilot stage.